Tyrosine

Tyrosine

SCHEMBL7434889

NCCCC[C@H](N)C(=O)OC(=O)[C@@H]1CCCN1.N[C@@H](Cc1ccc(O)cc1)C(=O)O

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 1/20 0.45
ITGB3 P05106 1/20 0.43
ITGA2B P08514 1/20 0.43
LNPEP Q9UIQ6 2/20 0.38
OPRM1 P35372 1/20 0.38
MAPT P10636 1/20 0.38
ERAP2 Q6P179 1/20 0.37
GSR P00390 1/20 0.35
THRB P10828 1/20 0.35
ITGA4 P13612 2/20 0.35
DPP4 P27487 1/20 0.35
NTSR2 O95665 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Proline SCHEMBL17728304 0.89 SLC7A5 (0.38) SLC7A5ITGB3ITGA2BLNPEPOPRM1
Proline SCHEMBL17728309 0.87 SLC7A5 (0.40) SLC7A5ITGB3ITGA2BLNPEPOPRM1
Tyrosine SCHEMBL9686139 0.87 SLC7A5 (0.50) SLC7A5
Tyrosine SCHEMBL15264616 0.87 SLC7A5 (0.50) SLC7A5ITGB3ITGA2BLNPEPOPRM1
Tyrosine SCHEMBL7434891 0.87 SLC7A5 (0.50) SLC7A5ITGB3ITGA2BLNPEPOPRM1
Tyrosine SCHEMBL4352798 0.87 SLC7A5 (0.57) SLC7A5OPRM1MAPTITGA4DPP4
SCHEMBL4205064 0.86 SLC7A5 (0.44) SLC7A5ITGA4DPP4
Tyrosine SCHEMBL6064435 0.86 SLC7A5 (0.46) SLC7A5OPRM1GSRITGA4DPP4
Tyrosine SCHEMBL2205275 0.85 SLC7A5 (0.47) SLC7A5ITGA4DPP4NTSR2
SCHEMBL17728303 0.84 SLC7A5 (0.46) SLC7A5ITGA4DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114980753-A Compositions and methods for improving and maintaining glucose metabolism in children and adolescents 雀巢产品有限公司 2022-08-30 CN disclosed
CN-114423304-A Compositions and methods for improvement and maintenance of weight loss 雀巢产品有限公司 2022-04-29 CN disclosed
EP-1144446-A1 PHARMACEUTICAL COMPOUNDS FOR THE INHIBITION OF HEPATITIS C VIRUS NS3 PROTEASE ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) 2001-10-17 EP disclosed
WO-2000031129-A1 PHARMACEUTICAL COMPOUNDS FOR THE INHIBITION OF HEPATITIS C VIRUS NS3 PROTEASE ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P ANGELETTI SPA (IT) 2000-06-02 WO disclosed